Tian An Medicare Limited to Hold Board Meeting on 13 March 2026

Tian An Medicare Limited (Stock Code: 383) has announced an upcoming meeting of its Board of Directors, scheduled for Friday, 13 March 2026. This meeting will be crucial for investors as the Board will discuss several significant matters that can directly impact the company’s share price and shareholder value.

Key Points from the Announcement

• Approval of Final Results: The Board will review and approve the final results for the financial year ended 31 December 2025. The publication of these results is a major event, as it provides insights into the company’s financial performance and strategic direction.
• Dividend Consideration: The Board will also consider the payment of a dividend, if any, for the year. Any decision on dividends is of high importance to shareholders as it directly affects their returns and may influence the market price of the company’s shares.
• Possible Share Price Sensitivity: The announcement and subsequent publication of the company’s annual results, as well as any decisions regarding dividend payments, are typically price-sensitive events. Investors often react to both the financial performance and the dividend policy, which can lead to increased volatility in the stock price.

Details for Shareholders

• The Board meeting is an essential step in the corporate calendar, as it will determine both the disclosure of the company’s audited financials and the potential payout to shareholders via dividends.
• The announcement was made by Sit Po Ling, the Company Secretary, and published on 3 March 2026 in Hong Kong.
• The composition of the Board includes a mix of Executive Directors, Non-Executive Directors (including the Chairman), and Independent Non-Executive Directors, reflecting a broad governance structure.

Potential Implications for Investors

• Financial Results: Investors should closely monitor the release of the annual results as they will provide an updated view of the company’s profitability, growth prospects, and operational efficiency.
• Dividend Decision: Any announcement of a dividend—whether initiation, increase, decrease, or omission—can be a strong signal about management’s confidence in the business and future cash flow expectations.
• Market Reaction: Given that both the results and dividend decision can move the share price, shareholders and potential investors are advised to stay alert around the date of the Board meeting and subsequent disclosures.

In summary: The scheduled Board meeting on 13 March 2026 is a price-sensitive event, as the company will announce its 2025 audited final results and consider a dividend. Shareholders and market participants should be prepared for potential movements in the company’s share price following these announcements.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult their financial advisor before making any investment decisions. The information presented is based on the company’s public announcement and may be subject to change.

View TIANAN MEDICARE Historical chart here